Detalhe da pesquisa
1.
Comparison of circulating tumor DNA between African American and Caucasian patients with metastatic castrate-resistant prostate cancer post-abiraterone and/or enzalutamide.
Prostate
; 83(11): 1028-1034, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-37113064
2.
Family history and pathogenic/likely pathogenic germline variants in prostate cancer patients.
Prostate
; 81(7): 427-432, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33760238
3.
Recycling Discarded Drugs: Improving Access to Oral Antineoplastic Drugs.
Oncologist
; 24(3): 291-292, 2019 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30568023
4.
Clinical and Genetic Analysis of Metastatic Prostate Cancer to the Central Nervous System: A Single-Institution Retrospective Experience.
Clin Genitourin Cancer
; 21(2): e9-e18, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36376168
5.
TP53 Gain-of-Function Mutations in Circulating Tumor DNA in Men With Metastatic Castration-Resistant Prostate Cancer.
Clin Genitourin Cancer
; 18(2): 148-154, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-31822380
6.
Non-AIDS defining cancers.
Med Health R I
; 93(10): 296-8, 2010 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-21284267
7.
High-Dose Testosterone and Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer.
Clin Genitourin Cancer
; 17(6): 476-479, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31537449
8.
Advanced blood management strategies for elective joint arthroplasty.
R I Med J (2013)
; 96(3): 23-5, 2013 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-23641434